Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Lancet Neurology

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(07)70195-3PMID 17689146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rivastigmine for Alzheimer's disease.

  2015cited by this paper
• Galantamine for vascular cognitive impairment.

  2006cited by this paper
• Progress in Clinical Neurosciences: Canadian Guidelines for the Development of Antidementia Therapies: A Conceptual Summary

  2006cited by this paper
• Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.

  2006cited by this paper
• Galantamine for Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease

  2006cited by this paper
• Donepezil for dementia due to Alzheimer's disease.

  2006cited by this paper
• Galantamine for vascular cognitive impairment.

  2006cited by this paper
• Memantine for dementia.

  2006cited by this paper
• Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials

  2005cited by this paper
• Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

  2005cited by this paper
• Rivastigmine for vascular cognitive impairment.

  2005cited by this paper
• The Cochrane Collaboration and the work of the Cochrane Dementia and Cognitive Improvement Group (CDCIG)

  2005cited by this paper
• Donepezil for vascular cognitive impairment.

  2004cited by this paper
• Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial

  2003cited by this paper
• Donepezil in vascular dementia

  2003cited by this paper
• Cholinesterase inhibitors for vascular dementia?

  2003cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Vascular dementia in a population-based autopsy study.

  2003cited by this paper
• Memantine in Vascular Dementia

  2003cited by this paper
• The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.

  2002cited by this paper
• Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

  2002cited by this paper
• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300)

  2002cited by this paper
• A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis.

  2002cited by this paper
• A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)

  2002cited by this paper
• ▼Rivastigmine for Alzheimer's disease

  2000cited by this paper
• Cholinesterase inhibitors: A new class of psychotropic compounds.

  2000cited by this paper
• Frequency and distribution of vascular dementia.

  1999cited by this paper
• Epidemiology of vascular dementia.

  1995cited by this paper
• Vascular dementia

  1993cited by this paper
• A population-based study of dementia in 85-year-olds.

  1993cited by this paper
• Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

  1992cited by this paper

• [Understanding and supporting vascular dementia after a stroke].

  2026cites this paper
• Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.

  2026cites this paper
• Effect of long‐term treatment with memantine on mortality in patients with major cognitive disorders: A systematic review and meta‐analysis

  2025cites this paper
• Problemi cognitivi di origine vascolare

  2025cites this paper
• Engineering exosomes for Alzheimer's disease: Multi‐target therapeutic strategies from pathogenesis to clinical translation

  2025cites this paper
• Network meta-analysis of the efficacy of pharmacological treatments for post-stroke cognitive impairment and vascular cognitive impairment

  2025cites this paper
• Bornyl Acetate and Menthol Provide Neuroprotection Against Lipopolysaccharide-Induced Alzheimer’s Disease-Like Condition in C57BL/6 Mice by Downregulating NARC-1 Lipid Antagonist

  2025cites this paper
• Electroacupuncture Preconditioning Ameliorates the Ischemic Microenvironment to Improve Long-Term Potentiation in Chronic Cerebral Hypoperfusion Rats With MGE Neural Progenitor Transplantation

  2025cites this paper
• Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer’s or mixed dementia: a real-world analysis using the quality registry SveDem

  2025cites this paper
• Acupuncture on Post-Stroke Cognitive Impairment: A Systematic Review of Neuroimaging Studies

  2025cites this paper
• Awareness of national dementia guidelines and management of oldest-old and frail people living with dementia: a European survey of geriatricians

  2025cites this paper
• [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

  2025cites this paper
• Vitamin C supplementation mitigates mild cognitive impairment in mice subjected to D-galactose: Insights into intestinal flora and derived SCFAs.

  2025cites this paper
• Incident dementia in ischaemic stroke patients with early cardiac complications: A propensity-score matched cohort study

  2024cites this paper
• Current and Future Treatments of Vascular Cognitive Impairment

  2024cites this paper
• Effect of transcranial direct current stimulation combined with transcutaneous auricular vagus nerve stimulation on poststroke cognitive impairment: a study protocol for a randomised controlled trial

  2024cites this paper
• Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease

  2024cites this paper
• Anti-dementia drugs: what is the evidence in advanced stages?

  2024cites this paper
• Risk factors and predictive markers of post-stroke cognitive decline–A mini review

  2024cites this paper
• Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing

  2024cites this paper
• Isoamericanin A ameliorates neuronal damage and alleviates vascular cognitive impairments by inhibiting oxidative stress through activation of the Nrf2 pathway.

  2024cites this paper
• Case report: a unique presentation of memantine overdose causing echolalia and hypertension

  2024cites this paper
• Polymer-Formulated Nerve Growth Factor Shows Effective Therapeutic Efficacy for Cerebral Microinfarcts.

  2024cites this paper
• Effect of non-invasive brain stimulation on post-stroke cognitive impairment: a meta-analysis

  2024cites this paper
• Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options

  2024cites this paper
• Mechanisms of glutamate metabolic function and dysfunction in vascular dementia

  2024cites this paper
• Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis

  2024cites this paper
• Clinical value of Alzheimer's disease biomarker testing

  2024cites this paper
• Troubles cognitifs d’origine vasculaire

  2024cites this paper
• Butylphthalide combined with donepezil for the treatment of vascular dementia: a meta-analysis

  2024cites this paper
• Exploring the neuroprotective role of physical activity in cerebral small vessel disease.

  2024cites this paper
• Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms

  2023cites this paper
• Treatment of Vascular Cognitive Impairment: A Bibliometric Analysis over a 12-Year Period

  2023cites this paper
• Kognitive Dysfunktion nach Schlaganfall

  2023cites this paper
• Unravelling the Threads: A Brief Insight into Vascular Dementia

  2023cites this paper
• Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association

  2023cites this paper
• Therapeutic dilemmas: cognitive enhancers and risk of falling in older adults—a clinical review

  2023cites this paper
• Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention

  2023cites this paper
• A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis

  2023cites this paper
• Daidzein Ameliorates Cerebral Ischemic-reperfusion Induced Neuroinflammation in Wistar Rats via Inhibiting NF-κB Signaling Pathway

  2023cites this paper
• Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis

  2023cites this paper
• Imaging, Genetic, and Pathological Features of Vascular Dementia

  2023cites this paper
• Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis

  2023cites this paper
• Integrated Network Pharmacology and Proteomic Analyses of Targets and Mechanisms of Jianpi Tianjing Decoction in Treating Vascular Dementia

  2023cites this paper
• Investigation of Cognitive Impairment in the Course of Post-COVID Syndrome

  2023cites this paper
• Effect of Huangdisan grain on improving cognitive impairment in VD rats and its mechanism in immune inflammatory response.

  2023cites this paper
• Feasibility, acceptability, and preliminary effectiveness of the adapted Namaste Care program delivered by caregivers of community-dwelling older persons with moderate to advanced dementia: a mixed methods feasibility study

  2022cites this paper
• Impacts of Game-based psychotherapy intervention to elderly with memory disorder

  2022cites this paper
• Comparative efficacy and acceptability of cholinesterase inhibitors and memantine based on dosage in patients with vascular cognitive impairment: a network meta-analysis.

  2022cites this paper
• Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia

  2022cites this paper
• [Pharmacotherapy in post-stroke rehabilitation].

  2022cites this paper
• Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation

  2022cites this paper
• Physical Exercise Exerts Neuroprotective Effect on Memory Impairment by Mitigate the Decline of Striatum Catecholamine and Spine Density in a Vascular Dementia Rat Model

  2022cites this paper
• Verification of Game-Based Psychotherapy Intervention Model for Elderly with Memory Disorder Using Expert Review Approach

  2022cites this paper
• Efficacy and safety of 3‐n‐butylphthalide for the treatment of cognitive impairment: A systematic review and meta‐analysis

  2022cites this paper
• Efficacy and safety of Chinese Herbal Medicine for Vascular dementia: A protocol of systematic review and meta-analysis

  2022cites this paper
• Genetic Deficiency of MicroRNA‐15a/16‐1 Confers Resistance to Neuropathological Damage and Cognitive Dysfunction in Experimental Vascular Cognitive Impairment and Dementia

  2022cites this paper
• Vascular dementia

  2022cites this paper
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer’s Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer’s Disease (DRAMA)

  2022cites this paper
• Different Exercise Time on 5-HT and Anxiety-like Behavior in the Rat With Vascular Dementia

  2022cites this paper
• Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study

  2022cites this paper
• Cranial manipulation affects cholinergic pathway gene expression in aged rats

  2022cites this paper
• Shengyu Decoction treating vascular cognitive impairment by promoting AKT/HIF-1α/VEGF related cerebrovascular generation and ameliorating MAPK/NF-κB mediated neuroinflammation.

  2022cites this paper
• Efficacy and safety of Buyang Huanwu-Tang (Boyang Hwano-Tang) in patients with vascular dementia

  2021cites this paper
• Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rat.

  2021cites this paper
• Emerging two-dimensional materials-enabled diagnosis and treatments of Alzheimer's disease: Status and future challenges

  2021cites this paper
• Luteolin Attenuates Cognitive Dysfunction Induced By Chronic Cerebral Hypoperfusion Through the Modulation of The PI3K/Akt Pathway in Rats

  2021cites this paper
• Dementia and Systemic Disease

  2021cites this paper
• Effectiveness and Safety of Acupuncture for Vascular Cognitive Impairment: A Systematic Review and Meta-Analysis

  2021cites this paper
• Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management

  2021cites this paper
• Effectiveness of Yijinjing on cognitive functions in post-stroke patients with mild cognitive impairment: study protocol for a randomized controlled trial

  2021cites this paper
• Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee

  2021cites this paper
• Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

  2021cites this paper
• Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.

  2021cites this paper
• Systematic review of the current psychosocial interventions for people with moderate to severe dementia

  2021cites this paper
• Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder

  2021cites this paper
• Vaskuläre Demenz

  2021cites this paper
• Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ

  2021cites this paper
• Anti-dementia Medication

  2021cites this paper
• Metal Ions-Mediated Oxidative Stress in Alzheimer’s Disease and Chelation Therapy

  2021cites this paper
• Systematic review of the current psychosocial interventions for people with moderate to severe dementia

  2021cites this paper
• Volume Analysis of Brain Cognitive Areas in Alzheimer’s Disease: Interim 3-Year Results from the ASCOMALVA Trial

  2020cites this paper
• Pharmacotherapy of non-Alzheimer's types of dementia

  2020cites this paper
• Drugs to Treat Dementia

  2020cites this paper
• Vaskuläre kognitive Beeinträchtigung und Demenz

  2020cites this paper
• Participatory design and evaluation of virtual reality games to promote engagement in physical activity for people living with dementia

  2020cites this paper
• Farmakoterapie nealzheimerovských typů demencí

  2020cites this paper
• Cornel Iridoid Glycoside Improves Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion via Activating PI3K/Akt/GSK-3β/CREB Pathway in Rats.

  2020cites this paper
• Alzheimer’s disease and other neurocognitive disorders

  2020cites this paper
• Time-dependent effects of platelet-rich plasma on the memory and hippocampal synaptic plasticity impairment in vascular dementia induced by chronic cerebral hypoperfusion.

  2020cites this paper
• Criteria of Mobile Psychotherapy Games for Memory Disorder: A Systematic Literature Review

  2020cites this paper
• Dynamic Memory Regeneration

  2020cites this paper
• Начальные проявления поражения головного мозга при артериальной гипертензии: клинический случай и возможности цитиколина

  2020cites this paper
• [White matter hyper-intensities in ageing: Pathophysiology, associated cognitive disorders and prevention].

  2020cites this paper
• Features of mental disorders and their correction in patients with cardiac pathology

  2020cites this paper
• Acupuncture Therapy for Cognitive Impairment: A Delphi Expert Consensus Survey

  2020cites this paper
• Psychotherapy Game For Elderly: Observation Experiences Of Psychotherapy Sessions At Rumah

  2020cites this paper
• Pharmacological Treatment: Current Evidence for Clinical Uses of Alzheimer’s Disease Drugs

  2020cites this paper
• Subcortical Vascular Cognitive Impairment

  2020cites this paper
• Effectiveness of Exergaming in Improving Cognitive and Physical Function in People With Mild Cognitive Impairment or Dementia: Systematic Review

  2020cites this paper